Longlive Bio-Technology’s losses continue to widen in H1

Summary:Longlive Bio-Technology released its first-half performance results of 2019 on 30 Aug., and the Company achieved operating income of USD29.17 million (RMB207 million), down by 59.62% YoY; net profit loss of USD31.50 million (RMB223 million), ...

Sweeteners China News 201909

www.cnchemicals.com